rs41276501

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The ENST00000326434.9(CRELD1):​c.1213C>G​(p.Gln405Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000757 in 800,866 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00068 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00078 ( 1 hom. )

Consequence

CRELD1
ENST00000326434.9 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.934

Publications

1 publications found
Variant links:
Genes affected
CRELD1 (HGNC:14630): (cysteine rich with EGF like domains 1) This gene encodes a member of a subfamily of epidermal growth factor-related proteins. The encoded protein is characterized by a cysteine-rich with epidermal growth factor-like domain. This protein may function as a cell adhesion molecule. Mutations in this gene are the cause of atrioventricular septal defect. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
PRRT3 (HGNC:26591): (proline rich transmembrane protein 3) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009648323).
BP6
Variant 3-9944066-C-G is Benign according to our data. Variant chr3-9944066-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 465833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000676 (103/152340) while in subpopulation AMR AF = 0.00144 (22/15296). AF 95% confidence interval is 0.000973. There are 0 homozygotes in GnomAd4. There are 54 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRELD1NM_001077415.3 linkc.1049-299C>G intron_variant Intron 10 of 10 ENST00000452070.6 NP_001070883.2 Q96HD1-1A0A024R2G1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRELD1ENST00000452070.6 linkc.1049-299C>G intron_variant Intron 10 of 10 2 NM_001077415.3 ENSP00000393643.2 Q96HD1-1
ENSG00000288550ENST00000683484.1 linkn.*697-299C>G intron_variant Intron 23 of 23 ENSP00000507040.1 A0A804HIF2

Frequencies

GnomAD3 genomes
AF:
0.000677
AC:
103
AN:
152222
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00106
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000586
AC:
146
AN:
249022
AF XY:
0.000682
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000491
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00112
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.000776
AC:
503
AN:
648526
Hom.:
1
Cov.:
6
AF XY:
0.000809
AC XY:
285
AN XY:
352230
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
18112
American (AMR)
AF:
0.000663
AC:
29
AN:
43748
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21092
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36132
South Asian (SAS)
AF:
0.0000428
AC:
3
AN:
70154
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53124
Middle Eastern (MID)
AF:
0.000717
AC:
3
AN:
4184
European-Non Finnish (NFE)
AF:
0.00118
AC:
433
AN:
368236
Other (OTH)
AF:
0.00104
AC:
35
AN:
33744
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
34
68
103
137
171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000676
AC:
103
AN:
152340
Hom.:
0
Cov.:
32
AF XY:
0.000725
AC XY:
54
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41582
American (AMR)
AF:
0.00144
AC:
22
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00106
AC:
72
AN:
68036
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000952
Hom.:
0
Bravo
AF:
0.000812
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.000601
AC:
73
EpiCase
AF:
0.00131
EpiControl
AF:
0.00172

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CRELD1: BP4, BS1, BS2 -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Atrioventricular septal defect, susceptibility to, 2 Benign:1
May 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CRELD1-related disorder Benign:1
Jun 21, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
4.7
DANN
Benign
0.92
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.052
N
LIST_S2
Benign
0.43
T
M_CAP
Benign
0.0071
T
MetaRNN
Benign
0.0096
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.93
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.14
N
REVEL
Benign
0.023
Sift
Benign
0.057
T
Sift4G
Pathogenic
0.0
D
Polyphen
0.029
B
Vest4
0.12
MVP
0.24
MPC
0.19
ClinPred
0.019
T
GERP RS
-2.0
gMVP
0.27
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41276501; hg19: chr3-9985750; COSMIC: COSV99926221; COSMIC: COSV99926221; API